Quality-Adjusted Life Years Concept

subject area of

• <p>Cost-Effectiveness Of Once-Daily Single-Inhaler Triple Therapy In COPD: The IMPACT Trial</p>  Academic Article
• Helicobacter pylori test and treat versus proton pump inhibitor in initial management of dyspepsia in primary care: multicentre randomised controlled trial (MRC-CUBE trial)  Academic Article
• A Cost-Effectiveness Analysis of Reverse Total Shoulder Arthroplasty versus Hemiarthroplasty for the Management of Complex Proximal Humeral Fractures in the Elderly  Academic Article
• A Cost-Effectiveness Model Comparing Endovascular Repair to Open Surgical Repair of Abdominal Aortic Aneurysms in Canada  Academic Article
• A One-Year Economic Evaluation of Six Alternative Strategies for the Management of Uninvestigated Upper Gastrointestinal Symptoms in Canadian Primary Care  Academic Article
• A Randomized Clinical Trial of Lung Volume Reduction Surgery Versus Best Medical Care for Patients With Advanced Emphysema: A Two-Year Study From Canada  Academic Article
• A Randomized Multicenter Trial to Evaluate Simple Utility Elicitation Techniques in Patients With Gastroesophageal Reflux Disease  Academic Article
• A Review of the Psychometric Properties of Generic Utility Measures in Multiple Sclerosis  Academic Article
• A Second-Order Simulation Model of the Cost-Effectiveness of Managing Dyspepsia in the United States  Academic Article
• A comparison between integrating clinical practice setting and randomized controlled trial setting into economic evaluation models of therapeutics  Academic Article
• A comparison of health utility scores calculated using United Kingdom and Canadian preference weights in persons with alzheimer’s disease and their caregivers  Academic Article
• A model to estimate health utilities index mark 3 utility scores from WOMAC index scores in patients with osteoarthritis of the knee.  Academic Article
• A pragmatic single-blind randomised controlled trial and economic evaluation of the use of leukotriene receptor antagonists in primary care at steps 2 and 3 of the national asthma guidelines (ELEVATE study).  Academic Article
• A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 2 of 2): economic results  Academic Article
• A review of health utilities across conditions common in paediatric and adult populations  Academic Article
• A view from the bridge: agreement between the SF-6D utility algorithm and the Health Utilities Index  Academic Article
• Active Surveillance, Radiofrequency Ablation, or Cryoablation for the Nonsurgical Management of a Small Renal Mass: A Cost-Utility Analysis  Academic Article
• Adjusting for Baseline Covariates in Net Benefit Regression: How You Adjust Matters  Academic Article
• Adolescent transport and unintentional injuries: a systematic analysis using the Global Burden of Disease Study 2019  Academic Article
• Age–sex differences in the global burden of lower respiratory infections and risk factors, 1990–2019: results from the Global Burden of Disease Study 2019  Academic Article
• Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016  Academic Article
• Alternatives to the QALY measure for economic evaluations  Academic Article
• An economic evaluation of early versus delayed operative treatment in patients with closed tibial shaft fractures  Academic Article
• An instrument to assess quality of life in relation to nutrition: item generation, item reduction and initial validation  Academic Article
• Analysis of Health Utility Data When Some Subjects Attain the Upper Bound of 1: Are Tobit and CLAD Models Appropriate?  Academic Article
• Analysis, Sample Size, and Power for Estimating Incremental Net Health Benefit from Clinical Trial Data  Academic Article
• Analyzing Oncology Clinical Trial Data Using the Q-TWiST Method: Clinical Importance and Sources for Health State Preference Data*  Academic Article
• Antiviral Agents for Influenza  Academic Article
• Are quality of life, patient preferences, and costs realistic outcomes for clinical trials?  Academic Article
• As Good As It Gets but Good Enough for Which Applications?  Academic Article
• Assessing Differences in Utility Scores: A Comparison of Four Widely Used Preference-Based Instruments  Academic Article
• Assessing performance of the Healthcare Access and Quality Index, overall and by select age groups, for 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019  Academic Article
• Assessing the impact of a home-based stroke rehabilitation programme: a cost-effectiveness study  Academic Article
• Assessing the use of health-related quality of life measures in the routine clinical care of lung-transplant patients  Academic Article
• Assessment of Utilities and Health-Related Quality of Life in Patients With Chronic Liver Disease  Academic Article
• Biennial lung cancer screening in Canada with smoking cessation—outcomes and cost-effectiveness  Academic Article
• Burden of diabetes and hyperglycaemia in adults in the Americas, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019  Academic Article
• Burden of injury along the development spectrum: associations between the Socio-demographic Index and disability-adjusted life year estimates from the Global Burden of Disease Study 2017  Academic Article
• COST-effectiveness of salmeterol/fluticasone propionate combination (Advair®) in uncontrolled asthma in Canada  Academic Article
• Can the value choices in DALYs influence global priority-setting?  Academic Article
• Canadian cost- utility analysis of intravenous immunoglobulin for acute childhood idiopathic thrombocytopenic purpura.  Academic Article
• Canadian cost-utility analysis of initiation and maintenance treatment with anti-TNF-α drugs for refractory Crohn's disease  Academic Article
• Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019  Academic Article
• Challenges to time trade-off utility assessment methods: when should you consider alternative approaches?  Academic Article
• Choices of Methodology in Pharmacoeconomic Studies  Academic Article
• Clinical impact and cost-effectiveness of integrating smoking cessation into lung cancer screening: a microsimulation model  Academic Article
• Clinically Important Differences in Q-TWIST – One Twist too Many?  Academic Article
• Commentary on Jack Dowie, ?Decision validity should determine whether a genericor condition-specific HRQOL measure is used in health care decisions?  Academic Article
• Commentary on Jack Dowie, ?Decision validity should determine whether a genericor condition-specific HRQOL measure is used in health care decisions?  Academic Article
• Community or patient preferences for cost-effectiveness of cardiac rehabilitation: does it matter?  Academic Article
• Comparison of health state utility estimates from instrument-based and vignette-based methods: a case study in kidney disease  Academic Article
• Comparison of the Deep Inferior Epigastric Perforator Flap and Free Transverse Rectus Abdominis Myocutaneous Flap in Postmastectomy Reconstruction: A Cost-Effectiveness Analysis  Academic Article
• Considering quality of life for children with cancer: a systematic review of patient-reported outcome measures and the development of a conceptual model  Academic Article
• Cost Avoidance Associated With Optimal Stroke Care in Canada  Academic Article
• Cost Effectiveness and Economic Impact of the KineSpring® Knee Implant System in the Treatment of Knee Osteoarthritis in Spain  Academic Article
• Cost Effectiveness of EML4-ALK Fusion Testing and First-Line Crizotinib Treatment for Patients With Advanced ALK-Positive Non–Small-Cell Lung Cancer  Academic Article
• Cost Effectiveness of Leukotriene Receptor Antagonists versus Inhaled Corticosteroids for Initial Asthma Controller Therapy  Academic Article
• Cost Effectiveness of Leukotriene Receptor Antagonists versus Long-Acting Beta-2 Agonists as Add-On Therapy to Inhaled Corticosteroids for Asthma  Academic Article
• Cost Effectiveness of Multi-Therapy Treatment Strategies in the Prevention of Vertebral Fractures in Postmenopausal Women with Osteoporosis  Academic Article
• Cost Effectiveness of Ventricular Tachycardia Ablation Versus Escalation of Antiarrhythmic Drug Therapy  Academic Article
• Cost Effectiveness of a Survivorship Care Plan for Breast Cancer Survivors  Academic Article
• Cost effectiveness analysis of population-based serology screening and 13C-Urea breath test for Helicobacter pylori to prevent gastric cancer: A markov model  Academic Article
• Cost per remission and cost per response with infliximab, adalimumab, and golimumab for the treatment of moderately-to-severely active ulcerative colitis  Academic Article
• Cost-Benefit Analyses in the Health-Care Literature: Don't Judge a Study by Its Label  Academic Article
• Cost-Effectiveness Analysis of 12-Versus 4-Weekly Administration of Bone-Targeted Agents in Patients with Bone Metastases from Breast and Castration-Resistant Prostate Cancer  Academic Article
• Cost-Effectiveness Analysis of Antiviral Treatments for HBeAg-Positive Chronic Hepatitis B in Canada  Academic Article
• Cost-Effectiveness Analysis of Zinc Supplementation for Treatment of Acute Diarrhea in Children Younger Than 5 Years in Colombia  Academic Article
• Cost-Effectiveness Analysis of a Randomized Trial Comparing Care Models for Chronic Kidney Disease  Academic Article
• Cost-Effectiveness and Cost-Utility of Long-Term Management Strategies for Heartburn  Academic Article
• Cost-Effectiveness and Economic Impact of the KineSpring® Knee Implant System in the Treatment of Knee Osteoarthritis in Italy  Academic Article
• Cost-Effectiveness and Economic Impact of the KineSpring® Knee Implant System in the Treatment of Knee Osteoarthritis in the United Kingdom  Academic Article
• Cost-Effectiveness of Different Forms of Intra-Articular Injections for the Treatment of Osteoarthritis of the Knee  Academic Article
• Cost-Effectiveness of Drug-Eluting Stents in a US Medicare Setting: A Cost-Utility Analysis with 3-Year Clinical Follow-Up Data  Academic Article
• Cost-Effectiveness of Lanthanum Carbonate in the Treatment of Hyperphosphatemia in Dialysis Patients: A Canadian Payer Perspective  Academic Article
• Cost-Effectiveness of Pharmacomechanical Catheter-Directed Thrombolysis Versus Standard Anticoagulation in Patients With Proximal Deep Vein Thrombosis  Academic Article
• Cost-Utility Analysis in Depression: The McSad Utility Measure for Depression Health States  Academic Article
• Cost-Utility Analysis of Discontinuing Antidepressants in England Primary Care Patients Compared with Long-Term Maintenance: The ANTLER Study  Academic Article
• Cost-Utility of Laparoscopic Nissen Fundoplication versus Proton Pump Inhibitors for Chronic and Controlled Gastroesophageal Reflux Disease: A 3-Year Prospective Randomized Controlled Trial and Economic Evaluation  Academic Article
• Cost-effectiveness analysis of Helicobacter pylori screening in prevention of gastric cancer in Chinese  Academic Article
• Cost-effectiveness analysis of a community paramedicine programme for low-income seniors living in subsidised housing: the community paramedicine at clinic programme (CP@clinic)  Academic Article
• Cost-effectiveness analysis of dabigatran and anticoagulation monitoring strategies of vitamin K antagonist  Academic Article
• Cost-effectiveness analysis of oxycodone with naloxone versus oxycodone alone for the management of moderate-to-severe pain in patients with opioid-induced constipation in Canada  Academic Article
• Cost-effectiveness analysis of secukinumab for the treatment of active psoriatic arthritis: a Canadian perspective  Academic Article
• Cost-effectiveness analysis of secukinumab in ankylosing spondylitis from the Canadian perspective  Academic Article
• Cost-effectiveness analysis of standalone trabecular micro-bypass stents in patients with mild-to-moderate open-angle glaucoma in Canada  Academic Article
• Cost-effectiveness and economic impact of the KineSpring® Knee Implant System in the treatment for knee osteoarthritis  Academic Article
• Cost-effectiveness evaluation of quadrivalent influenza vaccines for seasonal influenza prevention: a dynamic modeling study of Canada and the United Kingdom  Academic Article
• Cost-effectiveness of Dabigatran and Rivaroxaban Compared with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation  Academic Article
• Cost-effectiveness of Denosumab for the treatment of postmenopausal osteoporosis  Academic Article
• Cost-effectiveness of Lung Cancer Screening in Canada  Academic Article
• Cost-effectiveness of a shared computerized decision support system for diabetes linked to electronic medical records  Academic Article
• Cost-effectiveness of clopidogrel in acute coronary syndromes in Canada: A long-term analysis based on the CURE trial  Academic Article
• Cost-effectiveness of clopidogrel in acute coronary syndromes in Sweden: a long-term model based on the cure trial  Academic Article
• Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation: A Canadian payer perspective  Academic Article
• Cost-effectiveness of daclatasvir plus sofosbuvir-based regimen for treatment of hepatitis C virus genotype 3 infection in Canada  Academic Article
• Cost-effectiveness of denosumab in the treatment of postmenopausal osteoporosis in Canada  Academic Article
• Cost-effectiveness of reducing wait times for cataract surgery in Ontario  Academic Article
• Cost-effectiveness of romosozumab for the treatment of postmenopausal women at very high risk of fracture in Canada  Academic Article
• Cost-effectiveness to tolterodine for patients with urge incontinence who discontinue initial therapy with oxybutynin: A Canadian perspective  Academic Article
• Cost-utility analysis comparing free and pedicled TRAM flap for breast reconstruction  Academic Article
• Cost-utility and cost-benefit analyses  Academic Article
• Cost–Utility of Group Versus Individual Acupuncture for Cancer-Related Pain Using Quality-Adjusted Life Years in a Noninferiority Trial  Academic Article
• DEALE-ing with Lung Cancer and Heart Failure  Academic Article
• Dabigatran versus rivaroxaban for the prevention of stroke and systemic embolism in atrial fibrillation in Canada  Academic Article
• Decision Framework for Chemotherapeutic Interventions for Metastatic Non-Small-Cell Lung Cancer  Academic Article
• Deficits in preference-based health-related quality of life after complications associated with tibial fracture  Academic Article
• Describing the resource utilisation and costs associated withvertebral fractures: the Build Better Bones with Exercise (B3E) Pilot Trial  Academic Article
• Design and rationale for a pragmatic cluster randomized trial of the Cardiovascular Health Awareness Program (CHAP) for social housing residents in Ontario and Quebec, Canada  Academic Article
• Determing the threshold of acceptability of an ICER when natural health units are used.  Academic Article
• Development of the Galaxy Chronic Obstructive Pulmonary Disease (COPD) Model Using Data from ECLIPSE: Internal Validation of a Linked-Equations Cohort Model  Academic Article
• Development of the Health Awareness and Behaviour Tool (HABiT): reliability and suitability for a Canadian older adult population  Academic Article
• Different strategies for pharmacological thromboprophylaxis for lower-limb immobilisation after injury: systematic review and economic evaluation  Academic Article
• Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010  Academic Article
• Diseases, Injuries, and Risk Factors in Child and Adolescent Health, 1990 to 2017  Academic Article
• Double discounting of QALYs  Academic Article
• Economic Analysis of a Diabetes Health Coaching Intervention for Adults Living With Type 2 Diabetes: A Single-Centre Evaluation From a Community-Based Randomized Controlled Trial  Academic Article
• Economic Evaluation of Bevacizumab for the First-Line Treatment of Newly Diagnosed Glioblastoma Multiforme  Academic Article
• Economic Evaluation of Budesonide Orodispersible Tablets for the Treatment of Eosinophilic Esophagitis: A Cost–Utility Analysis  Academic Article
• Economic Evaluation of Early Psychosis Interventions From A Canadian Perspective  Academic Article
• Economic Evaluation of Palliative Care Interventions: A Review of the Evolution of Methods From 2011 to 2019  Academic Article
• Economic evaluation and health-related quality of life  Conference Paper
• Economic evaluation of HIV screening in pregnant women attending antenatal clinics in India  Academic Article
• Economic evaluation of drug-eluting stents compared to bare metal stents using a large prospective study in Ontario  Academic Article
• Economic evaluation of hematopoietic stem cell transplantation  Academic Article
• Economic evaluation of nivolumab for the treatment of second-line advanced squamous NSCLC in Canada: a comparison of modeling approaches to estimate and extrapolate survival outcomes  Academic Article
• Economic evaluation of the prophylaxis for thromboembolism in critical care trial (E-PROTECT): study protocol for a randomized controlled trial  Academic Article
• Economic evaluation of treatment for acute lymphoblastic leukaemia in childhood  Academic Article
• Economic evaluation of treatments for cancer in childhood  Academic Article
• Economics of Preoperative Radiotherapy With Total Mesorectal Excision: What Can We Learn From the Dutch Experience?  Academic Article
• Effect of Patient-Centered Transitional Care Services on Clinical Outcomes in Patients Hospitalized for Heart Failure  Academic Article
• Effect of preventive primary care outreach on health related quality of life among older adults at risk of functional decline: randomised controlled trial  Academic Article
• Eltrombopag for the treatment of chronic idiopathic (immune) thrombocytopenic purpura (ITP)  Academic Article
• Epidemiology of injuries from fire, heat and hot substances: global, regional and national morbidity and mortality estimates from the Global Burden of Disease 2017 study  Academic Article
• Epilepsy care in ontario: an economic analysis of increasing access to epilepsy surgery.  Academic Article
• Establishing disability weights for congenital pediatric surgical conditions: a multi-modal approach  Academic Article
• Establishing the minimal number of items for a responsive, valid, health-related quality of life instrument  Academic Article
• Estimates, trends, and drivers of the global burden of type 2 diabetes attributable to PM2·5 air pollution, 1990–2019: an analysis of data from the Global Burden of Disease Study 2019  Academic Article
• Estimating global injuries morbidity and mortality: methods and data used in the Global Burden of Disease 2017 study  Academic Article
• Examination of psychological risk factors for chronic pain following cardiac surgery: protocol for a prospective observational study  Academic Article
• Factors determining utility measured with the EQ-5D in patients with atrial fibrillation  Academic Article
• Five preference-based indexes in cataract and heart failure patients were not equally responsive to change  Academic Article
• Fragility Fractures: A Global Problem?  Academic Article
• Gambling with Gastroesophageal Reflux Disease: Should We Worry about the QALY?  Academic Article
• Gemcitabine/Dexamethasone/Cisplatin vs Cytarabine/Dexamethasone/Cisplatin for Relapsed or Refractory Aggressive-Histology Lymphoma: Cost-Utility Analysis of NCIC CTG LY.12  Academic Article
• Global and regional burden of cancer in 2016 arising from occupational exposure to selected carcinogens: a systematic analysis for the Global Burden of Disease Study 2016  Academic Article
• Global and regional burden of chronic respiratory disease in 2016 arising from non-infectious airborne occupational exposures: a systematic analysis for the Global Burden of Disease Study 2016  Academic Article
• Global and regional burden of disease and injury in 2016 arising from occupational exposures: a systematic analysis for the Global Burden of Disease Study 2016  Academic Article
• Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990–2010: findings from the Global Burden of Disease Study 2010  Academic Article
• Global and regional burden of stroke during 1990–2010: findings from the Global Burden of Disease Study 2010  Academic Article
• Global injury morbidity and mortality from 1990 to 2017: results from the Global Burden of Disease Study 2017  Academic Article
• Global trends of hand and wrist trauma: a systematic analysis of fracture and digit amputation using the Global Burden of Disease 2017 Study  Academic Article
• Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016  Academic Article
• Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017  Academic Article
• Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016  Academic Article
• Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017  Academic Article
• Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019  Academic Article
• Global, regional, and national burden of meningitis, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016  Academic Article
• Global, regional, and national burden of multiple sclerosis 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016  Academic Article
• Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016  Academic Article
• Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019  Academic Article
• Global, regional, and national burden of traumatic brain injury and spinal cord injury, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016  Academic Article
• Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015  Academic Article
• Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017  Academic Article
• Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016  Academic Article
• Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition  Academic Article
• Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015  Academic Article
• Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016  Academic Article
• Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017  Academic Article
• Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015  Academic Article
• Greater first year effectiveness drives favorable cost-effectiveness of brand risedronate versus generic or brand alendronate: modeled Canadian analysis  Academic Article
• HYEs: Do We Need Them and Can They Fulfil the Promise?  Academic Article
• Health Condition Impacts in a Nationally Representative Cross-Sectional Survey Vary Substantially by Preference-Based Health Index  Academic Article
• Health Utilities Index Mark 3 scores for major chronic conditions: Population norms for Canada based on the 2013 and 2014 Canadian Community Health Survey.  Academic Article
• Health Utility Scores in Alzheimer’s Disease: Differences Based on Calculation With American and Canadian Preference Weights  Academic Article
• Health economic evaluation of rivaroxaban in the treatment of patients with chronic coronary artery disease or peripheral artery disease  Academic Article
• Health years equivalents as a measurement of preferences for dental interventions.  Academic Article
• Health-Related Quality of Life and Cost-Effectiveness Components of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial: Rationale and Design  Academic Article
• Health-Related Quality-of-Life and Cost Utility Analyses in Critical Care: A Systematic Review*  Academic Article
• Health-related quality of life among children with acute lymphoblastic leukemia  Academic Article
• Health‐related quality of life in adolescents and young adults with cancer – Including a focus on economic evaluation  Academic Article
• How to use the results of an economic evaluation  Academic Article
• Identifying determinants of quality of life of children with cancer and childhood cancer survivors: a systematic review  Academic Article
• Impact of Adding Oseltamivir to Usual Care on Quality-Adjusted Life-Years During Influenza-Like Illness  Academic Article
• Impact of stent diameter and length on in-stent restenosis after DES vs BMS implantation in patients needing large coronary stents-A clinical and health-economic evaluation  Academic Article
• Impact of the 1997 Canadian Guidelines on the Conduct of Canadian-Based Economic Evaluations in the Published Literature  Academic Article
• Incremental cost-effectiveness ratios (ICERs): The silence of the lambda  Academic Article
• Incremental net benefit in randomized clinical trials with quality-adjusted survival  Academic Article
• Industry sponsorship bias in cost effectiveness analysis: registry based analysis  Academic Article
• Integrating Mortality and Morbidity Outcomes  Academic Article
• Internal validation of models with several interventions  Academic Article
• Is SABR Cost-Effective in Oligometastatic Cancer? An Economic Analysis of the SABR-COMET Randomized Trial  Conference Paper
• Is Screening for Atrial Fibrillation in Canadian Family Practices Cost-Effective in Patients 65 Years and Older?  Academic Article
• Is bad living better than good death? Impact of demographic and cultural factors on health state preference  Academic Article
• Is stratification testing for treatment of chronic obstructive pulmonary disease exacerbations cost-effective in primary care? an early cost-utility analysis  Academic Article
• Is there a kink in consumers' threshold value for cost-effectiveness in health care?  Academic Article
• Long-term cost-effectiveness of clopidogrel given for up to one year in patients with acute coronary syndromes without ST-segment elevation  Academic Article
• Long-term follow-up of survivors of acute lung injury: Lack of effect of a ventilation strategy to prevent barotrauma  Academic Article
• Low-intensity pulsed ultrasound for treatment of tibial fractures  Academic Article
• Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016  Academic Article
• Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015  Academic Article
• Measuring utilities of severe facial disfigurement and composite tissue allotransplantation of the face in patients with severe face and neck burns from the perspectives of the general public, medical experts and patients  Academic Article
• Methodology and measurement properties of health-related quality of life instruments: A prospective study of patients undergoing breast reduction surgery  Academic Article
• Modeling the Health and Economic Burden of Chronic Obstructive Pulmonary Disease in China From 2020 to 2039: A Simulation Study  Academic Article
• Modelling the Cost Effectiveness of Antidepressant Treatment in Primary Care  Academic Article
• Money matters: what to look for in an economic analysis  Academic Article
• Multiattribute Utility Function for a Comprehensive Health Status Classification System  Academic Article
• Multiattribute and Single-Attribute Utility Functions for the Health Utilities Index Mark 3 System  Academic Article
• NICE Methodological Guidelines and Decision Making in the National Health Service in England and Wales  Academic Article
• Network vs. Pairwise Meta-Analyses: A Case Study of the Impact of an Evidence-Synthesis Paradigm on Value of Information Outcomes  Academic Article
• Nonwage Losses Associated With Occupational Injury Among Health Care Workers  Academic Article
• On beingNICE in the UK: guidelines for technology appraisal for the NHS in England and Wales  Academic Article
• On the margins of health economics: a response to ‘resolving NICE’S nasty dilemma’  Academic Article
• Oral conditions contribute to a small proportion of the quality-adjusted life expectancy loss at age 20 years  Academic Article
• Oral steroids for hearing loss associated with otitis media with effusion in children aged 2–8 years: the OSTRICH RCT  Academic Article
• Patient Preferences and the Measurement of Utilities in the Evaluation of Dental Technologies  Academic Article
• Patient values and preferences on valve replacement for aortic stenosis: a systematic review  Academic Article
• Patient-focused measures of functional health status and health-related quality of life in pediatric orthopedics: a case study in measurement selection.  Academic Article
• Pharmacologic management of neovascular age-related macular degeneration: systematic review of economic evidence and primary economic evaluation  Academic Article
• Photodynamic Therapy for Barrett’s Esophagus with High-Grade Dysplasia: A Cost-Effectiveness Analysis  Academic Article
• Postmenopausal breast cancer: is the short-term pain worth the long-term gain?  Academic Article
• Potential Cost-Effectiveness of Ambulatory Cardiac Rhythm Monitoring After Cryptogenic Stroke  Academic Article
• Preference based measurements in dentistry: a review of the literature and recommendations for research.  Academic Article
• Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017  Academic Article
• QALY weights for neurosensory impairments in pediatric economic evaluations: case studies and a critique  Academic Article
• QALYs and HYEs Spotting the differences  Academic Article
• Quality-Adjusted Life-Year as a Surgical Outcome Measure: A Primer for Plastic Surgeons  Academic Article
• Quality-adjusted life years was a poor predictor of women's willingness to pay in acute and chronic conditions: results of a survey  Academic Article
• Quantifying the Disability from Congenital Anomalies Averted Through Pediatric Surgery: A Cross-Sectional Comparison of a Pediatric Surgical Unit in Kenya and Canada  Academic Article
• Recommendations for the conduct of economic evaluations in osteoporosis: outcomes of an experts’ consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the US branch of the International Osteoporosis Foundation  Academic Article
• Regression methods for cost-effectiveness analysis with censored data  Academic Article
• Relation of Distribution- and Anchor-Based Approaches in Interpretation of Changes in Health-Related Quality of Life  Academic Article
• Responsiveness of generic health-related quality of life measures in stroke  Academic Article
• Responsiveness to change to change due to supportive-expressive group therapy, improvement in mood and disease progression in women with metastatic breast cancer  Academic Article
• Results of a model analysis to estimate cost utility and value of information for intravenous immunoglobulin in canadian adults with chronic immune thrombocytopenic purpura  Academic Article
• Sample size and power issues in estimating incremental cost-effectiveness ratios from clinical trials data  Academic Article
• Screening and Prevention of Venous Thromboembolism in Critically Ill Patients  Academic Article
• Semi-parametric regression models for cost-effectiveness analysis: improving the efficiency of estimation from censored data  Academic Article
• Social factors in frequent callers: a description of isolation, poverty and quality of life in those calling emergency medical services frequently  Academic Article
• Spatial, temporal, and demographic patterns in prevalence of chewing tobacco use in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019  Academic Article
• Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019  Academic Article
• Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding  Academic Article
• Systematic reviews, economic evaluations, and practice guidelines: can research synthesis help us care for the critically ill?  Academic Article
• Tamoxifen for Breast Cancer Risk Reduction  Academic Article
• The Burden of Dementia due to Down Syndrome, Parkinson’s Disease, Stroke, and Traumatic Brain Injury: A Systematic Analysis for the Global Burden of Disease Study 2019  Academic Article
• The Burden of Mental Illness and Addiction in Ontario  Academic Article
• The Diagnosis of Urinary Tract Infection in Young Children (DUTY) Study Clinical Rule: Economic Evaluation  Academic Article
• The Gain in Quality-Adjusted Life Months by Switching to Esomeprazole in Those With Continued Reflux Symptoms in Primary Care: EncomPASS—A Cluster-Randomized Trial  Academic Article
• The Health Utilities Index (HUI): concepts, measurement properties and applications.  Academic Article
• The Impact of Anogenital Warts on Health-Related Quality of Life: A 6-Month Prospective Study  Academic Article
• The NICE Reference Case Requirement  Academic Article
• The PROMIS of QALYs  Academic Article
• The Technique, Resources and Costs of Stereotactic Body Radiotherapy of Prostate Cancer  Academic Article
• The Utility of Hand Transplantation in Hand Amputee Patients  Academic Article
• The additive utility assumption of the QALY model revisited  Academic Article
• The biggest bang for the buck or bigger bucks for the bang: the fallacy of the cost-effectiveness threshold  Academic Article
• The burden of disease in older people and implications for health policy and practice  Academic Article
• The burden of unintentional drowning: global, regional and national estimates of mortality from the Global Burden of Disease 2017 Study  Academic Article
• The burden of waiting: DALYs accrued from delayed access to pediatric surgery in Kenya and Canada  Conference Paper
• The cost effectiveness of minimally invasive spine surgery in the treatment of adult degenerative scoliosis: a comparison of transpsoas and open techniques  Academic Article
• The cost effectiveness of palivizumab in term Inuit infants in the Eastern Canadian Arctic  Academic Article
• The distribution problem in economic evaluation: income and the valuation of costs and consequences of health care programmes  Academic Article
• The economic burden of lung cancer and mesothelioma due to occupational and para-occupational asbestos exposure  Academic Article
• The feasibility and responsiveness of the health utilities index in patients with early-stage breast cancer: A prospective longitudinal study  Academic Article
• The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019  Academic Article
• The global, regional, and national burden of gastro-oesophageal reflux disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017  Academic Article
• The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017  Academic Article
• The global, regional, and national burden of stomach cancer in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease study 2017  Academic Article
• The health economics of Helicobacter pylori infection  Academic Article
• The health impact of delaying direct‐acting antiviral treatment for chronic hepatitis C: A decision‐analytic approach  Academic Article
• The impact of statistical properties of incremental monetary net benefit and incremental cost-effectiveness ratio on health economic modeling choices  Academic Article
• The ‘NICE’ Approach to Technology Assessment: An Economics Perspective  Academic Article
• Thrombosis: A major contributor to global disease burden  Academic Article
• Thrombosis: A major contributor to global disease burden  Academic Article
• Time-Specific Differences in Stated Preferences for Health in the United States  Academic Article
• To pay or not to pay? A decision and cost-utility analysis of angiotensin-converting-enzyme inhibitor therapy for diabetic nephropathy.  Academic Article
• Toward a Centralized, Systematic Approach to the Identification, Appraisal, and Use of Health State Utility Values for Reimbursement Decision Making: Introducing the Health Utility Book (HUB)  Academic Article
• Transforming Latent Utilities to Health Utilities: East Does Not Meet West  Academic Article
• Translation and cultural adaptation of Health Utilities Index (HUI) Mark 2 (HUI2) and Mark 3 (HUI3) with application to survivors of childhood cancer in Brazil  Academic Article
• Underestimation of Variance of Predicted Health Utilities Derived from Multiattribute Utility Instruments  Academic Article
• Understanding Costs and Cost-Effectiveness in Critical Care  Academic Article
• Unfinished Symphony: A Tribute to the Life and Career of Bernie O’Brien (1959–2004)  Academic Article
• Universal or Targeted Screening for Fetal Alcohol Exposure: A Cost-Effectiveness Analysis  Academic Article
• Update on the Global Burden of Ischemic and Hemorrhagic Stroke in 1990-2013: The GBD 2013 Study  Academic Article
• Use of a Disease-Specific Instrument in Economic Evaluations: Mapping WOMAC onto the EQ-5D Utility Index  Academic Article
• Users' guides to the medical literature. XII. How to use articles about health-related quality of life. Evidence-Based Medicine Working Group  Academic Article
• Using Linear Equating to Map PROMIS® Global Health Items and the PROMIS-29 V2.0 Profile Measure to the Health Utilities Index Mark 3  Academic Article
• Using Published Health Utilities in Cost-Utility Analyses: Discrepancies and Issues in Cardiovascular Disease  Academic Article
• Using existing data to identify candidate items for a health state classification system in multiple sclerosis  Academic Article
• Valuing Outcomes in Health Care  Academic Article
• Valuing the benefits and costs of health care programmes: where's the ‘extra’ in extra-welfarism?  Academic Article
• Visual analog scales: do they have a role in the measurement of preferences for health states?  Academic Article
• What Is Value in Health and Healthcare? A Systematic Literature Review of Value Assessment Frameworks  Academic Article
• Which cancer clinical trials should be considered for economic evaluation? Selection criteria from the National Cancer Institute of Canada's Working Group on Economic Analysis.  Academic Article
• Whose priorities count? Comparison of community-identified health problems and Burden-of-Disease-assessed health priorities in a district in Uganda  Academic Article
• Willingness to Pay and the Valuation of Programmes for the Prevention and Control of Influenza  Academic Article
• Willingness to pay for dentin regeneration in a sample of dentate adults  Academic Article
• Willingness to pay in the context of an economic evaluation of healthcare programs: theory and practice.  Academic Article
• Willingness-to-pay (WTP): the new-old kid on the economic evaluation block.  Academic Article
• World Health Organization Global Estimates and Regional Comparisons of the Burden of Foodborne Disease in 2010  Academic Article
• Would scan, but which scan? A cost-utility analysis to optimize preoperative imaging for primary hyperparathyroidism  Academic Article
• Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010  Academic Article